MJBizDaily Newsletter

Get our daily email

More Exclusive Features

Full financial effect of Canada’s recreational marijuana ‘soft launch’ may be years away

When Canada becomes the first Group of Seven country to legalize recreational cannabis on Wednesday, market observers say it will amount to a “soft launch,” with the full financial effect of this multibillion-dollar industry still years from being realized. The early months will be marked by a small number of stores, limited product selection and […]

Read More

Ahead of Canada’s big day, forecast for cannabis industry gets a boost

On the eve of Canada’s historic launch of its recreational marijuana program, the global cannabis industry appears poised for explosive growth thanks to the confluence of a host of market developments. “The well-capitalized cannabis industry has been evolving rapidly and looks to address a far larger (market) than we had originally forecast,” Wall Street analyst […]

Read More

Chart: The days of CBD-only stores may be numbered

While hemp and marijuana may be close relatives, most hemp-derived CBD retailers don’t sell the products alongside medical cannabis. But as state laws around cannabidiol continue to change, stand-alone CBD stores may become a relic. According to estimates from Hemp Industry Daily in the 2018 Hemp & CBD Industry Factbook, CBD sales in the U.S. are expected to […]

Read More

Week in Review: Sweet Leaf owners make a deal, NJ/IL medical cannabis reform & Alaska tax revamp

Sweet Leaf’s owners strike a deal with Colorado marijuana regulators, New Jersey and Illinois take steps to bolster their medical cannabis markets, and Alaska overhauls its MJ business taxes. Here’s a closer look at some notable developments in the cannabis industry this week. Sweet Leaf hit hard The owners of the once high-flying Colorado marijuana […]

Read More

Canadian regulator wants cannabis companies to disclose US border risk

Canada’s securities watchdog is warning the country’s publicly traded marijuana companies to improve their disclosure practices – including any risks tied to their executives and employees crossing into the United States – or face additional regulatory action. The warning came in a detailed notice published Oct. 10 by the Canadian Securities Administrators (CSA), an umbrella […]

Read More

MedMen inks blockbuster $682 million stock deal to acquire medical cannabis firm PharmaCann

MedMen Enterprises has agreed to acquire multistate medical marijuana company PharmaCann in an all-stock deal valued at $682 million, inking what is believed to be the largest acquisition to date in the U.S. cannabis industry. The deal will double the number of states where Los Angeles-based MedMen has licenses to operate – expanding the firm’s […]

Read More